Share Name Share Symbol Market Type Share ISIN Share Description
Carclo LSE:CAR London Ordinary Share GB0001751915 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -1.24% 79.50p 78.20p 80.80p 80.80p 80.80p 80.80p 10,368 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 146.2 8.2 11.6 6.9 58.26

Carclo Share Discussion Threads

Showing 17826 to 17850 of 17850 messages
Chat Pages: 714  713  712  711  710  709  708  707  706  705  704  703  Older
DateSubjectAuthorDiscuss
13/10/2018
11:12
Peel Hunt has been wrong with their Carclo forecasts for more years than I can recall - probably for ever, lol. Think for yourselves, boys and girls. Look at the never-ending tooling costs. Look at the missed expectations. Look at the slump in car sales - China down some 12%. They should've flogged off LED, cleared debt and bigged-up on TP. Aerospace is ok because it gives them some cash-flow. Takeover hopes only.
poikka
13/10/2018
01:48
Thanks for the comment. Makes sense but I think that a company that has been so poorly managed needs to over communicate. I don't care what the broker is telling them - it is nonsense to relate comments to their internal expectations and not give any specifics. If the yardstick is Peel Hunt's forecasts - they could at as minimum tell investors what Peel Hunt is forecasting?
overmars
12/10/2018
17:20
Overmars - I think this "management expectations" is something forced on them by their advisors. I went to another company's AGM recently and had asked them specifically, ahead of the meeting, if they could explain the background to a TU they had put out which talked about being significantly ahead of their expectations - then when the full year results came out they actually showed flat (or fractionally declining) YOY 2H revenues. So they came prepared and what they said was that their advisors (the Nomad) said they needed to inform the market if they expected any material metric to be more than a certain % (maybe 10%?) away from what the brokers' reports were forecasting - in the case of this company it was fairly straightforward as there was really only one broker covering it. But the advisor also said they shouldn't really say "market expectations" - presumably because someone litigious could dispute what those were. So they ended up having to say "management expectations". I think this is perhaps quite common among smaller companies. They work closely with an advisor/broker and while not formally "guiding" the broker effectively they provide sufficient information to allow the broker to come up with reasonable forward estimates (and in some cases I suspect they rely on the broker to come up with these estimates because they don't have a great internal capability to do so). So coming back to Carclo and today's "warning", I think I would interpret it as saying that they don't think they are going to meet the house broker (Peel Hunt) expectations for 1H. Has Peel Hunt published a 1H/2H split does anyone know? Does anyone have a different view?
1gw
12/10/2018
16:56
Very poorly worded statement. Performance is measured relative to board’s expectations. They need to be specific about their expectations. How are investors supposed to know what those expectations are?
overmars
12/10/2018
14:03
https://www.edisoninvestmentresearch.com/research/report/carclo599434/full If management are correct that the loss of sales in the first half is recovered in the 2nd half then based on the Edison update it looks like its worth continuing to hold.
pj84
12/10/2018
10:42
Thanks Rivaldo, and you make a good point that at the Interims they will have two months second half trading to report on, which is probably what I'll hang on for before deciding what to do here.
nick rubens
12/10/2018
10:37
Extract from Trading Update Sept 17Technical Plastics has had a challenging start to the financial year with some key new programmes delayed into the second half and some operational challenges, which have now been largely resolved.I think there's an echo in here...
gleach23
12/10/2018
10:06
Cheers owenski, appreciated. Nor do I :o)) I simply see the two core divisions as very good businesses, with high recurring income and good visibility going forward once new medical and auto programmes are won and implemented. And with potential for very large growth and global expansion. Old management screwed things up. New management have at least re-focused the company on those core divisions, but have either made mistakes/been subject to repeated programme timing fluctuations (depending on your point of view!) which have stymied progress to date. After today yet again we'll have to wait and see for a while. However, today's news exudes positivity going forward, so I'll hold (once again!) in the belief that the core value is far in excess of the current share price.
rivaldo
12/10/2018
09:21
You're a pretty shrewd guy Rivaldo, I've never understood why you stick with this one.
owenski
12/10/2018
09:18
Peel Hunt have reiterated their Buy and 130p price target today: Http://investing.thisismoney.co.uk/broker-views/ Nick Rubens, N+1 Singer and Edison both have around the same forecasts, at 11.4p EPS this year and 12.4p/12.5p EPS next year. Assuming the interims in November reiterate the confidence in full year expectations - being two months into H2 at that stage - then the current price will look very cheap. Even if full year EPS turns out at say 9p-10p EPS, at 78p the downside shouldn't be too bad compared to some of the catastrophes seen recently :o))
rivaldo
12/10/2018
09:04
Incompetent management. Plus the guy who cashed in his chips on the massive spike-he clearly knew it would amount to nothing. Bunch of monkeys sums it up.
meijiman
12/10/2018
08:36
Been in and out of this dawg so many times, I'm getting sore. Fact - this bunch of monkeys have been misleading investors (intentionally, or not) for over a decade. Those in any doubt, check back to their statements - same old stuff (like today's) right from when they were telling us about the prospects for CIT. Short term traders only, long term it's a massive gamble - yes, a gamble. Takeover possibilities are there in that the company would be split, but don't bet the house.
poikka
12/10/2018
08:28
It's an old school Carclo statement! Foundations excellent for next period. It was ever thus.
queeny2
12/10/2018
08:16
Anyone know what the full year profit expectation is? They claim they expect to meet it, but it sounds like the Interim's are going to be a cause for concern to investors?
nick rubens
12/10/2018
07:53
Level 2 Heavily marked down before open Currently 75/78 - Ouch if stays at this level.
pugugly
12/10/2018
07:32
Reading the RNS, it seems that all the new programmes necessary for the required improvement in H2 are now in place in both the TP and LED divisions. So you can understand the company's confidence in their prospects for the year. Which doesn't mean that with the markets in their current state there won't be an understandable reaction today to the disappointing H1 underperformance at TP.
rivaldo
12/10/2018
07:27
Can we have another bid approach please? It seems like they are hoping for a lot of things to go well in 2H to meet their full year expectations.
1gw
12/10/2018
07:24
1gw hard to say. I was fearing worse!
queeny2
12/10/2018
07:23
Carclo plc ("the Group")Trading update ? full year expectations unchangedTrading in the first half was below the Board's expectations due to underperformance at Technical Plastics.In Technical Plastics, three new medical programmes were delayed by customers in the period but all entered productionsuccessfully towards the end of the first half of the year and this, together with planned new tooling programmes, supportthe expected stronger second half performance. The implementation of our operational improvement programme hasdelivered a number of price increases, efficiency opportunities and cost savings across the division, the benefit of whichwill positively impact margins in the second half of the year and beyond.In the LED Division, Wipac has continued to be successful in winning new programmes, including nomination for two mid?volume electric vehicles, leading to a healthy level of design and development contract profits. Production demand hasbeen solid. All of the current year's planned new vehicle production programmes launched in the first half and thisresulted in higher than anticipated manufacturing costs being incurred during launch. Associated margins are expected toimprove in the second half as production accelerates and initial start?up inefficiencies are eliminated.The smaller Aerospace Division performed slightly ahead of expectations as a result of higher margins and tight controlover costs.The Board's expectations for the year ending 31 March 2019 remain unchanged, with results weighted towards the secondhalf of the year, as expected. This reflects the full effect of the new programmes, expected customer timings on projectsand the anticipated improvement in margins at Wipac in addition to cost saving initiatives, ramp up in production volumesand expected higher design and tooling profits in Technical Plastics.The Group will announce its interim results for the period ended 30 September 2018 on 13 November 2018.For further information please contact:Carclo plcChris Malley, Chief Executive
queeny2
12/10/2018
07:16
And that would be another profit warning wouldn't it? Albeit they say they're going to recover things in 2H.
1gw
02/10/2018
19:40
Huge selling activity today... I am afraid that there is another round of bad news on the horizon...
gordongekko4
18/9/2018
15:45
Rivaldo agree, we could/perhaps should have one. Should anybody care, I have no position, having sold all of my long after the bidder walked away. That a well financed well prepared sector bidder (leaving LED aside) cannot make the numbers work at such lowly multiples of sales does worry me, especially when coupled with the previously announced full review of underlying profitability at technical plastics and sacking of FD. I hope for the company's sake and holders that the defence was based upon a sunlit uplands future for the company, but if it is I suspect it's a year or three out. I'm not short, which I was before the bid, because I'm a) too confused to have a position and b) it is very cheap on any basic multiple basis.
queeny2
18/9/2018
15:12
Queeny2, given the AGM was so much earlier this year, perhaps we'll get an H1 trading update at some point at the end of this month/early October. As for VR315, CAR and VEC initially developed the Gyrophaler device together: Https://www.investegate.co.uk/article.aspx?id=200412060700100322G This is used in the AirFluSal® Forspiro® product marketed by Sandoz - formerly known as VR315: Https://aerosol-soc.com/abstracts/overview-design-verification-testing-process-gyrohaler-dry-powder-inhaler/
rivaldo
12/9/2018
22:29
Jordan-based drugmaker Hikma acquired the VR315 product when it bought Roxane Laboratories, with whom Vectura, a UK-based developer of inhaled therapies, had been partnerning in developing the product. - hxxps://www.thepharmaletter.com/article/vectura-and-hikma-s-generic-of-gsk-s-asthma-drug-advair-diskus-accepted-for-filing-by-us-fda
gordongekko4
12/9/2018
22:23
Rivaldo, please share your source regarding partnership between Carclo and Vectura re VR315
gordongekko4
Chat Pages: 714  713  712  711  710  709  708  707  706  705  704  703  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20181022 21:00:25